Literature DB >> 11217368

Tyrosine kinase inhibitors against EGF receptor-positive malignancies.

E A Sudbeck1, S Ghosh, X P Liu, Y Zheng, D E Myers, F M Uckun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11217368     DOI: 10.1385/1-59259-114-0:193

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


× No keyword cloud information.
  3 in total

1.  Modelling methicillin-resistant Staphylococcus aureus decolonization: interactions between body sites and the impact of site-specific clearance.

Authors:  Onur Poyraz; Mohamad R A Sater; Loren G Miller; James A McKinnell; Susan S Huang; Yonatan H Grad; Pekka Marttinen
Journal:  J R Soc Interface       Date:  2022-06-15       Impact factor: 4.293

Review 2.  Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance.

Authors:  Yi-Jun Wang; Yun-Kai Zhang; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

3.  WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells.

Authors:  Hui Zhang; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Atish Patel; Hua Zhu; Kamlesh Sodani; Tanaji T Talele; Suresh V Ambudkar; Zhe-Sheng Chen; Li-Wu Fu
Journal:  Cancer Sci       Date:  2014-08-21       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.